Notification on the change of Application fee for Product dossier assessment

August 3rd, 2017

19/DRA/DC/Notification/2016-2017/40

Regulatory Notification

DRA would like to notify that the application fee for product dossier assessment has been revised to Nu. 500 (Five hundred) based on the consensus of the stakeholders and approval from the Sixteenth meeting of the Bhutan Medicines Board. This is notification shall come into force from 03 August, 2017.

Please click on the link below to view the Notification:
Regulatory notification on regulation of Drug of Abuse test kits

March 8th, 2023
Notification on rescheduling of clients visiting time for efficient service delivery

February 7th, 2023
Competency Examination on 20th February 2023

January 24th, 2023
Regulatory Notification on Substandard (contaminated) paediatric medicines identified in WHO region of Africa.

October 6th, 2022
Competency Examination on 27th October 2022

October 3rd, 2022
Notification on Requirement of Technical Authorization for sales, distribution of Medical Devices and Registration of Medical Devices

August 31st, 2022